object
sever
acut
respiratori
syndrom
sar
like
diseas
due
novel
betacoronaviru
human
coronaviru
emc
hcovemc
emerg
recent
hcovemc
phylogenet
close
relat
hong
kong
conduct
seropreval
studi
archiv
sera
gamefood
anim
handler
wild
life
market
sar
patient
healthi
blood
correspond
author
journal
infect
crossreact
antibodi
neutral
seropreval
donor
southern
china
assess
zoonot
potenti
evid
intrus
hcovemc
relat
virus
human
method
antihcovemc
antisarscov
antibodi
detect
use
screen
indirect
immunofluoresc
confirmatori
neutral
antibodi
test
result
two
anim
handler
antibodi
titer
hcovemc
sarscov
neutral
antibodi
titer
blood
donor
antibodi
either
viru
surprisingli
sar
patient
signific
antibodi
titer
antihcovemc
neutral
antibodi
low
titer
significantli
correl
bioinformat
analysi
demonstr
signific
bcell
epitop
overlap
heptad
region
spike
protein
virul
sarscov
betacoronavirus
may
boost
crossreact
neutral
antibodi
betacoronavirus
conclus
convalesc
sar
sera
may
contain
crossreact
antibodi
betacoronavirus
confound
seropreval
studi
hcovemc
emerg
novel
human
coronaviru
emc
hcovemc
middl
east
sinc
april
far
led
case
human
infect
fatal
march
first
laboratoryconfirm
case
report
world
health
organ
septemb
index
case
man
jeddah
kingdom
saudi
arabia
present
sever
acut
communityacquir
pneumonia
acut
renal
failur
june
later
succumb
june
despit
maxim
support
treatment
sputum
sampl
obtain
admiss
show
cytopath
chang
suggest
viru
replic
vero
cell
posit
coronaviru
pancoronaviru
rtpcr
subsequ
phylogenet
analysi
viral
genom
sequenc
show
viru
novel
coronaviru
close
genet
related
discov
lesser
bamboo
bat
tylonycteri
pachypu
japanes
pipistrel
bat
pipistrellu
abramu
hong
kong
china
respect
close
relat
coronavirus
also
found
bat
speci
europ
ghana
second
case
man
qatar
kept
camel
sheep
farm
travel
histori
kingdom
saudi
arabia
symptom
onset
develop
sever
acut
communityacquir
pneumonia
acut
renal
failur
requir
extracorpor
membran
oxygen
intens
care
unit
london
lower
respiratori
tract
sampl
posit
coronaviru
use
pancoronaviru
rtpcr
bp
pcr
fragment
viral
isol
first
case
show
sequenc
homolog
nucleotid
mismatch
region
compar
subsequ
laboratoryconfirm
case
hcovemc
infect
report
middl
east
unit
kingdom
total
kingdom
saudi
arabia
qatar
jordan
unit
arab
emir
unit
kingdom
case
develop
sever
pneumonia
least
case
concomit
acut
renal
failur
case
die
unusu
high
crude
fatal
rate
sever
clinic
manifest
acut
respiratori
renal
failur
uniqu
among
human
coronaviru
infect
sourc
transmiss
seropreval
hcovemc
well
establish
present
highli
pathogen
virus
capabl
caus
epidem
sar
coronaviru
sarscov
avian
influenza
viru
anim
sourc
viru
lead
interspeci
jump
human
possibl
hypothesi
support
epidemiolog
link
anim
exposur
patient
laboratoryconfirm
hcovemc
infect
close
phylogenet
related
hcovemc
tybatcov
pibatcov
broad
speci
tropism
hcovemc
differ
anim
cell
includ
bat
primat
swine
civet
rabbit
humantohuman
transmiss
appear
limit
stage
epidemiologicallylink
cluster
identifi
far
jordanian
cluster
retrospect
trace
back
april
evid
spread
moreov
none
resid
kingdom
saudi
arabia
serum
antibodi
hcovemc
thu
hcovemc
like
differ
human
coronavirus
associ
mild
respiratori
tract
infect
name
account
respiratori
infect
gener
popul
serum
antibodi
rather
may
similar
sarscov
cross
speci
barrier
natur
bat
reservoir
intermedi
amplif
anim
host
human
caus
sever
infect
subclin
nonpneumon
infect
gener
popul
order
substanti
hypothesi
hcovemc
zoonot
agent
elicit
evid
intrus
hcovemc
relat
virus
human
studi
antibodi
titer
use
immunofluoresc
screen
neutral
confirmatori
test
atrisk
group
work
wild
life
market
guangzhou
southern
china
constantli
expos
wide
rang
game
food
anim
sar
patient
might
acquir
infect
directli
wild
anim
healthi
blood
donor
studi
approv
institut
review
board
hospit
author
hong
kong
archiv
sera
obtain
subject
belong
atrisk
group
work
wild
life
market
guangzhou
patient
laboratoryconfirm
sar
rtpcr
healthi
blood
donor
hong
kong
special
administr
region
southern
china
retriev
c
refriger
atrisk
group
consist
game
food
anim
market
retail
anim
slaughter
anim
transport
personnel
subject
age
year
anim
handler
mean
age
year
rang
year
maletofemal
ratio
exposur
live
andor
dead
chicken
duck
gees
pigeon
sparrow
seagul
turtledov
crane
fox
wild
boar
sika
deer
rabbit
andor
cat
averag
exposur
time
year
rang
month
year
clinic
isol
hcovemc
kindli
provid
fouchier
zaki
et
al
isol
amplifi
one
addit
passag
vero
cell
line
make
work
stock
viru
experiment
protocol
involv
live
hcovemc
coronaviru
isol
follow
standard
oper
procedur
approv
biosafeti
facil
previous
describ
hcovemc
sarscovinfect
vero
cell
smear
use
studi
smear
prepar
previous
describ
briefli
cell
earli
evid
cytopath
effect
cpe
shown
round
cell
invert
microscopi
cell
harvest
trypsin
air
dri
tefllon
slide
immunocel
int
mechelen
belgium
fix
chill
aceton
min
c
store
c
use
indirect
immunofluoresc
antibodi
test
fig
antihcovemc
antisarscov
antibodi
detect
perform
use
indirect
previous
describ
slight
modif
sera
screen
dilut
infect
noninfect
control
cell
c
min
cell
wash
twice
pb
min
time
antihuman
igg
inova
diagnost
san
diego
ad
cell
smear
incub
min
c
sera
posit
screen
dilut
titrat
serial
dilut
posit
result
score
fluoresc
intens
equal
higher
posit
control
use
previou
studi
hcovemc
antibodi
test
vero
cell
infect
moi
h
harvest
infect
cell
coat
teflon
slide
air
dri
fix
chill
aceton
c
min
kept
c
use
guinea
pig
antin
hyperimmun
sera
prepar
posit
control
test
new
batch
infect
noninfect
cell
togeth
nonimmun
guinea
pig
sera
neg
control
posit
neg
guinea
control
sera
includ
run
antibodi
test
antibodi
titer
taken
highest
serum
dilut
give
posit
result
antibodi
titer
determin
sera
posit
antihcovemc
antibodi
titer
sera
inactiv
c
min
neutral
antibodi
test
start
serum
dilut
serial
dilut
sera
prepar
microtit
plate
previous
describ
serum
dilut
ml
mix
ml
tissu
cultur
infecti
dose
tcid
hcovemc
sarscov
incub
c
h
co
incub
ml
virusserum
mixtur
inocul
duplic
well
microtit
plate
preform
monolay
vero
cell
incub
c
day
viru
backtitr
perform
assess
actual
viru
titer
use
experi
cpe
observ
use
invert
microscop
day
postinocul
neutral
antibodi
titer
determin
highest
dilut
serum
complet
suppress
cpe
least
half
infect
well
experi
read
viru
backtitr
show
viru
dose
tcid
expect
mous
antiwhol
hcovemc
hyperimmun
sera
use
posit
control
sera
posit
neutral
antibodi
titer
repeat
confirm
neutral
antibodi
titer
determin
sera
posit
hcovemc
antibodi
titer
amino
acid
sequenc
protein
hcovemc
sarscov
download
ncbi
genbank
structurebas
sequenc
align
domain
hcovemc
sarscov
perform
server
immunogen
region
contain
potenti
human
bcell
epitop
predict
use
epitopia
transmembran
domain
preced
cytoplasm
tail
predict
use
tmhmm
version
heptad
repeat
region
within
domain
predict
use
marcoil
fisher
exact
test
use
determin
differ
proport
group
posit
antibodi
titer
nt
anim
handler
healthi
blood
donor
sar
patient
healthi
blood
donor
anim
handler
sar
patient
comput
perform
use
predict
analyt
soft
ware
pasw
version
window
correl
neutral
antibodi
titer
hcovemc
sarscov
perform
use
ibm
spss
statist
titer
regard
respect
pvalu
consid
statist
signific
two
anim
handler
work
wild
game
food
anim
market
south
china
posit
antihcovemc
igg
detect
indirect
titer
tabl
case
man
exposur
pigeon
year
case
man
exposur
chicken
duck
gees
year
also
posit
antisarscov
igg
indirect
titer
igg
titer
tabl
case
adequ
archiv
serum
test
neutral
antibodi
titer
anoth
anim
handler
posit
antisarscov
igg
indirect
antisarscov
neutral
antibodi
tabl
none
anim
handler
antihcovemc
neutral
antibodi
among
sar
patient
posit
antihcovemc
igg
detect
indirect
titer
rang
tabl
titer
patient
igg
detect
indirect
tabl
surprisingli
sar
patient
also
low
titer
antihcovemc
neutral
antibodi
less
neutral
antibodi
antisarscov
neutral
antibodi
found
major
sar
patient
expect
high
titer
four
sar
patient
pair
acut
convalesc
sera
avail
comparison
tabl
antihcovemc
igg
titer
rose
acut
sera
convalesc
sera
patient
signific
rise
two
patient
also
rise
antibodi
titer
anoth
human
betacoronaviru
none
healthi
blood
donor
antihcovemc
antisarscov
antibodi
indirect
neutral
tabl
overal
signific
correl
indirect
igg
titer
hcovemc
sarscov
pearson
correl
p
neutral
antibodi
titer
hcovemc
sarscov
pearson
correl
p
subgroup
analysi
sar
patient
posit
antihcovemc
andor
neutral
antibodi
correl
strongest
antibodi
sarscov
pearson
correl
neutral
antibodi
respect
p
case
littl
amino
acid
sequenc
ident
receptorbind
domain
protein
hcovemc
sarscov
protein
show
amino
acid
sequenc
ident
epitopia
use
predict
immunogen
region
might
bcell
epitop
domain
epitop
predict
align
region
hcovemc
sarscov
unlik
crossneutr
antibodi
would
occur
region
sequenc
ident
predict
epitop
two
virus
low
fig
three
two
immunogen
region
predict
domain
hcovemc
sarscov
respect
fig
immunogen
region
identifi
hcovemc
overlap
predict
region
sarscov
notabl
identifi
immunogen
region
sarsi
emcii
overlap
heptad
repeat
region
domain
hcovemc
sarscov
known
harbor
epitop
broadli
neutral
antibodi
case
sarscov
look
evid
intrus
novel
betacoronaviru
hcovemc
atrisk
group
gener
popul
convalesc
sar
patient
sera
found
contain
signific
titer
antibodi
betacoronavirus
posit
correl
antibodi
titer
sarscov
hcovemc
use
indirect
neutral
antibodi
test
find
crossreact
antibodi
unexpect
could
induc
crossreact
epitop
structur
protein
nucleoprotein
abund
structur
protein
coronavirus
previous
report
inde
crossreact
antibodi
among
human
betacoronavirus
well
known
made
larg
scale
surveil
studi
epidemiolog
survey
human
coronaviru
infect
difficult
hand
crossreact
neutral
antibodi
among
betacoronavirus
rare
report
except
close
relat
human
palm
civet
sarscov
signific
neutral
antibodi
titer
hcovemc
sar
patient
sera
studi
surpris
neutral
gener
consid
specif
serolog
test
previou
surveil
studi
show
antisarscov
neutral
antibodi
popul
extrem
low
despit
high
seropreval
antibodi
zaki
colleagu
also
fail
detect
crossreact
antihcovemc
antibodi
among
patient
kingdom
saudi
arabia
like
also
serum
andor
antibodi
furthermor
none
healthi
blood
donor
present
studi
serum
antihcovemc
antibodi
detect
indirect
neutral
therefor
assess
structur
homolog
betacoronavirus
possibl
explan
observ
crossreact
neutral
antibodi
surfac
protein
ectodomain
spike
induc
signific
neutral
antibodi
augment
matrix
e
envelop
protein
though
absent
hcovemc
complet
exclud
possibl
similar
protein
code
accessori
protein
gene
homolog
search
reveal
presenc
similar
protein
betacoronavirus
use
protein
attach
fusion
virion
host
cell
membran
trimer
protein
form
peplom
radiat
lipid
envelop
give
viru
characterist
corona
solislik
appear
electron
microscop
spike
protein
ectodomain
consist
domain
domain
contain
receptor
bind
domain
respons
recognit
bind
host
cell
receptor
fragment
amino
acid
receptor
bind
domain
case
sarscov
howev
homolog
sarscov
hcovemc
low
amino
acid
ident
inde
region
gener
diverg
rel
region
coronavirus
henc
region
induc
major
neutral
antibodi
convalesc
sera
sar
patient
would
unlik
result
antibodi
signific
crossneutr
activ
domain
respons
fusion
contain
put
fusion
peptid
heptad
repeat
bind
cellular
receptor
trigger
conform
chang
colloc
fusion
peptid
upstream
two
heptad
repeat
transmembran
domain
final
fusion
viral
cellular
lipid
envelop
epitop
situat
amino
acid
around
heptad
repeat
subunit
like
induc
crossreact
neutral
antibodi
hcovemc
sarscov
phylogenet
antigen
epitop
analysi
suggest
area
highli
conserv
among
tabl
titer
antihumancoronavirus
antibodi
immunofluoresc
andor
neutral
sar
patient
avail
pair
acut
convalesc
serum
sampl
tabl
case
tabl
specimen
b
case
convalesc
tabl
case
tabl
specimen
tabl
case
c
convalesc
tabl
specimen
b
case
tabl
case
convalesc
tabl
specimen
c
test
perform
due
insuffici
quantiti
archiv
sera
betacoronavirus
therefor
could
complet
explain
presenc
crossreact
antihcovemc
neutral
antibodi
among
sar
patient
gener
popul
postul
addit
structur
homolog
hcovemc
sarscov
differ
clinic
manifest
subsequ
host
immunolog
respons
infect
may
account
pattern
neutral
antibodi
crossreact
sarscov
caus
sever
infect
viremia
predominantli
caus
superfici
mucos
infect
upper
respiratori
tract
selflimit
therefor
unlik
highli
virul
sarscov
hcovemc
induc
solid
humor
immun
respons
insuffici
b
cell
matur
process
failur
induc
high
avid
antibodi
like
occur
figur
structurebas
protein
sequenc
align
region
hcovemc
sarscov
construct
use
http
receptor
bind
domain
highlight
ident
similar
residu
shade
black
grey
respect
immunogen
region
predict
epitopia
least
residu
length
highlight
black
line
repres
sequenc
viru
use
improv
clariti
present
betacoronaviru
infect
gener
popul
neutral
antibodi
titer
less
virul
betacoronavirus
boost
superimpos
sarscov
hcovemc
infect
tabl
viral
clinic
immunolog
differ
may
explain
absenc
crossreact
neutral
antibodi
sarscov
hcovemc
normal
blood
donor
despit
expos
past
find
import
implic
serodiagnost
test
treatment
develop
vaccin
prevent
human
infect
caus
betacoronavirus
possibl
crossreact
antibodi
give
rise
falseposit
result
concur
suggest
recent
report
use
antihcovemc
antibodi
test
patient
clear
epidemiolog
linkag
besid
possibl
wrong
serodiagnosi
due
crossreact
observ
would
support
use
antivir
peptid
treatment
emerg
hcovemc
infect
antivir
peptid
target
heptad
repeat
success
use
neutral
sarscov
cell
cultur
furthermor
antigen
epitop
could
import
vaccin
target
though
danger
immunopatholog
must
also
consid
possibl
low
level
neutral
antibodi
lead
immun
enhanc
also
consid
sar
convalesc
plasma
normal
intraven
immunoglobulin
use
treatment
hcovemc
infect
definit
evid
intrus
hcovemc
atrisk
group
found
present
studi
two
sera
anim
handler
indirect
antibodi
hcovemc
sarscov
specif
neutral
activ
toward
virus
though
due
crossreact
betacoronavirus
possibl
crossreact
tybatcov
pibatcov
remain
distinct
possibl
may
repres
sporad
interspeci
jump
high
risk
group
inde
coronavirus
found
mani
mammalian
avian
speci
repeatedli
cross
speci
barrier
caus
interspeci
transmiss
throughout
histori
occasion
caus
major
zoonot
outbreak
disastr
consequ
phylogenet
analysi
show
lineag
betacoronaviru
might
jump
bovin
sourc
figur
structurebas
protein
sequenc
align
region
hcovemc
sarscov
construct
use
http
ident
similar
residu
shade
black
grey
respect
immunogen
region
predict
epitopia
least
residu
length
highlight
black
line
heptad
repeat
region
highlight
repres
sequenc
viru
use
improv
clariti
present
human
recent
exampl
interspeci
transmiss
jump
lineag
b
betacoronaviru
sarscov
bat
civet
human
caus
sar
epidem
though
seropreval
antihcovemc
antibodi
found
indic
posit
among
resid
kingdom
saudi
arabia
demograph
detail
particularli
histori
anim
exposur
describ
studi
includ
seropreval
studi
refin
serolog
test
conduct
among
atrisk
group
middl
east
confirm
zoonot
natur
emerg
human
coronaviru
number
limit
studi
first
rel
small
number
sar
patient
test
lack
archiv
sera
howev
posit
antihcovemc
igg
titer
group
high
valu
made
result
less
ambigu
would
interest
test
larger
group
laboratoryconfirm
sar
patient
differ
viral
strain
substanti
observ
second
low
seropreval
antisarscov
gener
popul
make
possibl
wrong
serodiagnost
due
crossreact
less
import
routin
diagnost
howev
find
essenti
confirm
serolog
surveil
studi
especi
southeast
asian
countri
includ
china
seropreval
antisarscov
may
well
establish
hcovemc
may
continu
spread
caus
epidem
dens
popul
area
futur
